fatigue; body aches; joint pain; stiff neck; headaches; bruising; muscle weakness; tingling in fingers/toes; lightheadedness; nerve pain/ neuropathy through my whole body; widescale inflammation; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Jul2021 (Lot number: EW0177) at the age of 32 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hashimotos thyroiditis" (unspecified if ongoing); "Endometriosis" (unspecified if ongoing); "Factor V Leiden" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; PROGESTERONE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0217, Location of injection: Arm Left), administration date: 18Jun2021, when the patient was 32 years old, for Covid-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 31Jul2021, outcome "recovering", described as "fatigue"; PAIN (non-serious) with onset 31Jul2021, outcome "recovering", described as "body aches"; ARTHRALGIA (non-serious) with onset 31Jul2021, outcome "recovering", described as "joint pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 31Jul2021, outcome "recovering", described as "stiff neck"; HEADACHE (non-serious) with onset 31Jul2021, outcome "recovering", described as "headaches"; CONTUSION (non-serious) with onset 31Jul2021, outcome "recovering", described as "bruising"; MUSCULAR WEAKNESS (non-serious) with onset 31Jul2021, outcome "recovering", described as "muscle weakness"; PARAESTHESIA (non-serious) with onset 31Jul2021, outcome "recovering", described as "tingling in fingers/toes"; DIZZINESS (non-serious) with onset 31Jul2021, outcome "recovering", described as "lightheadedness"; NEURALGIA (non-serious) with onset 31Jul2021, outcome "recovering", described as "nerve pain/ neuropathy through my whole body"; INFLAMMATION (non-serious) with onset 31Jul2021, outcome "recovering", described as "widescale inflammation". The events "fatigue", "body aches", "joint pain", "stiff neck", "headaches", "bruising", "muscle weakness", "tingling in fingers/toes", "lightheadedness", "nerve pain/ neuropathy through my whole body" and "widescale inflammation" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue, pain, arthralgia, musculoskeletal stiffness, headache, contusion, muscular weakness, paraesthesia, dizziness, neuralgia, inflammation.  Additional Information: Seriousness criteria-Results in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating and Congenital anomaly/birth defect was no. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Reported Event: 3 weeks after the 2nd dose of Pfizer covid vaccine, Patient began to have fatigue, body aches, joint pain, stiff neck, headaches, bruising, muscle weakness, tingling in fingers/toes, lightheadedness and nerve pain/ neuropathy through my whole body. She went to the Emergency department and a full assessment was done. Nothing could be found wrong. Did a large panel of labs with Dr. and  was ruled out to have MS or any Autoimmune conditions. It looks the cause could be widescale inflammation. The Dr. has deemed that this is a vaccine injury after receiving the 2nd covid vaccine. The patient would appreciate it if Pfizer could look into the cause of these medical conditions arising for some, as she have come across more people who have had similar adverse reactions, especially neurological. She have now been going through this for 4 months and her life has changed drastically. She is a medical professional and apprehensive to get the booster shot by the reaction she had. She is a healthy induvial. No Hospitalization Prolonged. The adverse event result in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No Relevant past drug history. Prior to vaccination, was the patient was diagnosed with COVID-19. Since the vaccination, has the patient had been tested for COVID-19. The patient did not provide information regarding the reported adverse event(s) with the use of the product.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101541169 Same reporter/product, similar event, different patient